Cost-effectiveness of FRAX®-based intervention thresholds for management of osteoporosis in Singaporean women

M. Chandran, G. Ganesan, K. B. Tan, J-Y Reginster, M. Hiligsmann*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

5 Citations (Web of Science)
Original languageEnglish
Pages (from-to)133-144
Number of pages12
JournalOsteoporosis International
Volume32
Issue number1
Early online date14 Aug 2020
DOIs
Publication statusPublished - Jan 2021

Keywords

  • Alendronate
  • Cost-effectiveness analysis
  • FRAX
  • Intervention thresholds
  • Osteoporosis
  • Singapore
  • QUALITY-OF-LIFE
  • POSTMENOPAUSAL WOMEN
  • MEDICATION ADHERENCE
  • SUBSEQUENT FRACTURE
  • ECONOMIC BURDEN
  • HIP FRACTURE
  • RISK
  • MORTALITY
  • MEN
  • BISPHOSPHONATES

Cite this